Multimodal AI platform for oncology drug development and precision medicine
BostonGene integrates genomic, transcriptomic, immune, and clinical data through a foundation model designed for cancer research and therapeutic development. The tech stack—Python, Kubernetes, Airflow, Prefect, AWS—reflects a data-engineering-heavy operation built to handle complex biomarker pipelines at scale. Current hiring skews toward commercial roles (sales director, marketing) and clinical infrastructure (medical, data), suggesting a shift from pure R&D toward go-to-market execution and customer-facing analytics.
Notable leadership hires: Sales Director, Legal Director
BostonGene develops an AI platform that maps tumor microenvironments and immune biology to accelerate drug discovery and optimize patient stratification. The company combines real-world clinical data from academic cancer centers with biopharma partnerships to generate actionable insights across preclinical, clinical, and commercial stages. Founded in 2015 and headquartered in Waltham, MA, BostonGene operates within oncology and immunotherapy, working with global pharmaceutical and biotech leaders. The operational footprint spans the United States and Armenia, with active projects centered on clinical report automation, data pipeline reliability, and demand generation.
Python, Docker, Kubernetes, Apache Airflow, Prefect, and AWS infrastructure. The stack is optimized for ETL/ELT pipelines and clinical data processing at scale.
Waltham, Massachusetts. The company also hires in Armenia and operates across the United States.
Other companies in the same industry, closest in size